Dear Friends,
It is with both a sense of accomplishment and anticipation that I announce my transition from 最新麻豆原创 staff. After a rewarding tenure, I鈥檒l be joining Stanford Medicine Children鈥檚 Health as Senior Vice President and Chief Government Relations Officer, starting full time in July.
During my years at 最新麻豆原创, I鈥檝e been privileged to work with an extraordinary team of staff, trustees, volunteers, and partners. Together, we鈥檝e made significant strides in building a healthier and more equitable Silicon Valley, touching thousands of lives and driving impactful changes across the region. As I prepare to take on new challenges, I鈥檓 deeply grateful for the experiences and relationships fostered within this incredible community.
The board has unanimously and enthusiastically voted to appoint Amy Chan as the Interim CEO, effective June 28, 2024. Amy brings a robust track record of success at 最新麻豆原创, having managed our $120 million investment portfolio and $20 million annual budget. With a background as an auditor and financial manager in high-profile organizations like PricewaterhouseCoopers and Colgate-Palmolive, Amy has been pivotal in enhancing our operational frameworks and financial health. Her leadership in adopting new technologies and streamlining processes ensures that 最新麻豆原创 is on solid footing to continue our mission. Her passion for health equity in Silicon Valley is evident in her years of C-suite leadership with AACI and 最新麻豆原创.
I鈥檓 also pleased to share that I鈥檒l be joining the board of 最新麻豆原创, allowing me to remain connected and supportive of the organization鈥檚 continued success.
Thank you for your support and partnership. I look forward to staying connected and hope our paths continue to intersect in the future.
Sincerely,
Michele Lew